145 related articles for article (PubMed ID: 27577214)
21. Genetic dosage compensation via co-occurrence of PMP22 duplication and PMP22 deletion.
Hirt N; Eggermann K; Hyrenbach S; Lambeck J; Busche A; Fischer J; Rudnik-Schöneborn S; Gaspar H
Neurology; 2015 Apr; 84(15):1605-6. PubMed ID: 25795643
[No Abstract] [Full Text] [Related]
22. Rapid detection of duplication/deletion of the PMP22 gene in patients with Charcot-Marie-Tooth disease Type 1A and hereditary neuropathy with liability to pressure palsy by real-time quantitative PCR using SYBR Green I dye.
Kim SW; Lee KS; Jin HS; Lee TM; Koo SK; Lee YJ; Jung SC
J Korean Med Sci; 2003 Oct; 18(5):727-32. PubMed ID: 14555828
[TBL] [Abstract][Full Text] [Related]
23. Molecular diagnosis of PMP22 gene duplications and deletions: comparison of different methods.
Stangler Herodez S; Zagradisnik B; Erjavec Skerget A; Zagorac A; Kokalj Vokac N
J Int Med Res; 2009; 37(5):1626-31. PubMed ID: 19930872
[TBL] [Abstract][Full Text] [Related]
24. [Roussy-Lévy syndrome with a duplication on peripheral myelin protein gene (PMP22)].
Wake Y; Kanzaki A; Shirabe T
Rinsho Shinkeigaku; 2000 Jul; 40(7):750-2. PubMed ID: 11186918
[TBL] [Abstract][Full Text] [Related]
25. Absence of PMP22 coding region mutations in CMT1A duplication patients: further evidence supporting gene dosage as a mechanism for Charcot-Marie-Tooth disease type 1A.
Warner LE; Roa BB; Lupski JR
Hum Mutat; 1996; 8(4):362-5. PubMed ID: 8956042
[No Abstract] [Full Text] [Related]
26. Increased gene dosage of myelin protein zero causes Charcot-Marie-Tooth disease.
Maeda MH; Mitsui J; Soong BW; Takahashi Y; Ishiura H; Hayashi S; Shirota Y; Ichikawa Y; Matsumoto H; Arai M; Okamoto T; Miyama S; Shimizu J; Inazawa J; Goto J; Tsuji S
Ann Neurol; 2012 Jan; 71(1):84-92. PubMed ID: 22275255
[TBL] [Abstract][Full Text] [Related]
27. A novel point mutation in the peripheral myelin protein 22 (PMP22) gene associated with Charcot-Marie-Tooth disease type 1A.
Marrosu MG; Vaccargiu S; Marrosu G; Vannelli A; Cianchetti C; Muntoni F
Neurology; 1997 Feb; 48(2):489-93. PubMed ID: 9040744
[TBL] [Abstract][Full Text] [Related]
28. Thr(118)Met amino acid substitution in the peripheral myelin protein 22 does not influence the clinical phenotype of Charcot-Marie-Tooth disease type 1A due to the 17p11.2-p12 duplication.
Marques W; Sweeney MG; Wood NW
Braz J Med Biol Res; 2003 Oct; 36(10):1403-7. PubMed ID: 14502374
[TBL] [Abstract][Full Text] [Related]
29. Molecular diagnosis and clinical onset of Charcot-Marie-Tooth disease in Japan.
Abe A; Numakura C; Kijima K; Hayashi M; Hashimoto T; Hayasaka K
J Hum Genet; 2011 May; 56(5):364-8. PubMed ID: 21326314
[TBL] [Abstract][Full Text] [Related]
30. The modifying effect a PMP22 deletion in a family with Charcot-Marie-Tooth type 1 neuropathy due to an EGR2 mutation.
Reményi V; Inczédy-Farkas G; Gál A; Bereznai B; Pál Z; Karcagi V; Mechler F; Molnár MJ
Ideggyogy Sz; 2014 Nov; 67(11-12):420-5. PubMed ID: 25720245
[TBL] [Abstract][Full Text] [Related]
31. A Novel Missense Mutation in Peripheral Myelin Protein-22 Causes Charcot-Marie-Tooth Disease.
Li LX; Dong HL; Xiao BG; Wu ZY
Chin Med J (Engl); 2017 Aug; 130(15):1779-1784. PubMed ID: 28748849
[TBL] [Abstract][Full Text] [Related]
32. [The clinical presentation and gene mutation of probands in Chinese patients with Charcot-Marie-Tooth disease].
Liu X; Fan D; Song S
Zhonghua Nei Ke Za Zhi; 2015 Jul; 54(7):623-7. PubMed ID: 26359026
[TBL] [Abstract][Full Text] [Related]
33. Charcot-Marie-Tooth 1A: heterozygous T118M mutation over a CMT1A duplication has no influence on the phenotype.
Seeman P; Mazanec R; Marikova T; Rautenstrauss B
Ann N Y Acad Sci; 1999 Sep; 883():485-9. PubMed ID: 10586280
[No Abstract] [Full Text] [Related]
34. Patients homozygous for the 17p11.2 duplication in Charcot-Marie-Tooth type 1A disease.
LeGuern E; Gouider R; Mabin D; Tardieu S; Birouk N; Parent P; Bouche P; Brice A
Ann Neurol; 1997 Jan; 41(1):104-8. PubMed ID: 9005872
[TBL] [Abstract][Full Text] [Related]
35. Novel mutations in the Charcot-Marie-Tooth disease genes PMP22, MPZ, and GJB1.
Huehne K; Benes V; Thiel C; Kraus C; Kress W; Hoeltzenbein M; Ploner CJ; Kotzian J; Reis A; Rott HD; Rautenstrauss BW
Hum Mutat; 2003 Jan; 21(1):100. PubMed ID: 12497641
[TBL] [Abstract][Full Text] [Related]
36. Characterization of a Portuguese family with Charcot-Marie-Tooth disease type 1E due to a novel point mutation in the PMP22 gene.
Fernandes M; Caetano A; Castelhano L; Santos L
Clin Neurol Neurosurg; 2021 Sep; 208():106829. PubMed ID: 34332267
[TBL] [Abstract][Full Text] [Related]
37. Molecular and clinical features of inherited neuropathies due to PMP22 duplication.
Watila MM; Balarabe SA
J Neurol Sci; 2015 Aug; 355(1-2):18-24. PubMed ID: 26076881
[TBL] [Abstract][Full Text] [Related]
38. Nonrecurrent 17p11.2p12 Rearrangement Events that Result in Two Concomitant Genomic Disorders: The PMP22-RAI1 Contiguous Gene Duplication Syndrome.
Yuan B; Harel T; Gu S; Liu P; Burglen L; Chantot-Bastaraud S; Gelowani V; Beck CR; Carvalho CM; Cheung SW; Coe A; Malan V; Munnich A; Magoulas PL; Potocki L; Lupski JR
Am J Hum Genet; 2015 Nov; 97(5):691-707. PubMed ID: 26544804
[TBL] [Abstract][Full Text] [Related]
39. Duplication of the PMP22 gene in 17p partial trisomy patients with Charcot-Marie-Tooth type-1 neuropathy.
Roa BB; Greenberg F; Gunaratne P; Sauer CM; Lubinsky MS; Kozma C; Meck JM; Magenis RE; Shaffer LG; Lupski JR
Hum Genet; 1996 May; 97(5):642-9. PubMed ID: 8655146
[TBL] [Abstract][Full Text] [Related]
40. Compound Charcot-Marie-Tooth disease may determine unusual and milder phenotypes.
Gouvea SP; S Borghetti VH; Bueno KC; Genari AB; Lourenço CM; Sobreira C; Barreira AA; Marques W
Neurogenetics; 2010 Feb; 11(1):135-8. PubMed ID: 19705173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
